CD8A and neoplasm: In the context of squamous cell carcinoma, C5a has been demonstrated to facilitate the pro-tumor characteristics of C5aR1+ mast cells and macrophages, whilst simultaneously inhibiting CD8+ T cell cytotoxicity and limiting chemotherapy-induced T cell responses, supporting the growth of tumors (55).